Providence, RI - In a new study, even mild degrees of preoperative anemia or polycythemia (high red blood cell count) were associated with an increased risk of 30-day postoperative mortality and ...

THE measurement of the packed red-cell volume (or hematocrit) of the venous blood has long been recognized as a useful aid in the study of blood in a large number of clinical conditions. The technic ...

ATLANTA -- Maintaining patients with polycythemia vera at hematocrit levels below 45% reduced thrombotic complications without increasing rates of other serious adverse events compared with a higher ...

Please provide your email address to receive an email when new articles are posted on . High hematocrit levels were observed among 8.4% of adults receiving gender-confirming testosterone therapy.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio ORLANDO, Fla. — Among patients with Crohn ...

SAN DIEGO -- A novel therapy for polycythemia vera (PCV) maintained stable hematocrit levels for as long as 2.5 years and significantly reduced use of phlebotomy, a small randomized trial showed. The ...

Credit: Thinkstock. The risk of hematocrit elevation may depend on testosterone therapy's route of administration, according to investigators. A rise in hematocrit levels occurs with 4 months of ...

DURHAM, N.C. -- When physicians routinely "thin" the blood of patients undergoing coronary artery bypass surgery in order to place them on the heart-lung machine, they may be causing more damage to ...

Rusfertide maintained hematocrit control below 45% and reduced phlebotomy eligibility in PV patients through 52 weeks in the VERIFY study. Patients switching from placebo to rusfertide showed rapid ...

Patients with polycythemia vera (PV) taking the investigational therapy rusfertide were able to largely maintain hematocrit control and avoid the need for phlebotomy over 52 weeks, according to ...

Researchers explored the incidence of erythrocytosis in the first 20 months of testosterone therapy among people receiving gender-affirming hormone therapy (GAHT). Specifically, they conducted a ...

IN normal persons chronic hypoxia results in polycythemia. This phenomenon has been recognized and studied in high-altitude dwellers, and data obtained from such studies have come to be accepted as ...